For older people and frail people, the long-term benefit of medicines reduces and the potential for harm from adverse effects increases. When the benefit–risk balance changes in this way, medicine review and optimisation are important to simplify the therapeutic regimen, reduce inappropriate medicines and minimise risks. In this article, pharmacist prescriber Linda Bryant uses two case studies to illustrate important considerations during medicine reviews
Group of doctors urge colleagues to read the End of Life Choice Bill
Group of doctors urge colleagues to read the End of Life Choice Bill

This opinion piece has been submitted by 10 retired and working doctors - Jack Havill, Libby Smales, Dame Margaret Sparrow, Lannes Johnson, Angel Hancock, John Musgrove, James Davidson, Alison Glover, Stanley Koshy and Frank Kueppers. Further details of the authors are provided at the end of the article
Kia ora and welcome to New Zealand Doctor Rata Aotearoa
Not a subscriber? Unlock this article by subscribing here.
1. Havill J. Physician Assisted Dying – a survey of Waikato general practitioners. NZ Med J 2015;128(1409):70-71, 20 Feb 20
2.Poll of Doctors on Assisted Dying. New Zealand Doctor July 2015
3.Oliver Pam, Wilson M, Malpas Phillipa. New Zealand doctor’s and nurses’ views on legalising assisted dying in NZ. NZ Med J 2017;130(1456): 2 June
4. Malpas Phillipa, Mitchell Kay, Koschwanez Heidi. End-of-life medical decision making in general practice in NZ – 13 years on. NZ Med J 2015;128(1418):27-39, 24 July
5 Bernheim J, Deschepper R, Diselmans W, Mullie A, Bilsen J, Deliens J. Development of palliative care and legalization of euthanasia: antagonism or synergy? 2008;336:864-67
6.Wollongong University Health Services Unit – see submission by Dr Libby Smales to Health Select Committee on Assisted Dying.)
7. Dying Badly – NZ Stories, Havill and Barber. Online – see ‘Yestodignity’ website